News

Initial public offerings scheduled to debut next week

NEW YORK, N.Y. – The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.

Week of September 14:

Nabriva Therapeutics AG – Vienna, Austria, 6 million American depositary shares, each representing 100 common shares, priced $15 to $17, managed by Leerink Partners, and RBC Capital Markets. Proposed Nasdaq symbol NBRV. Business: Developing a novel antibiotic for bacterial pneumonia.

Penumbra Inc. – Alameda, Calif., 3.8 million shares, priced $25 to $28, managed by J.P. Morgan, and BofA Merrill Lynch. Proposed NYSE symbol PEN. Business: Markets devices for neuro and peripheral vascular conditions and diseases.

RegenexBio – Rockville, Md., 5.6 million shares, priced $17 to $19, managed by Morgan Stanley, and BofA Merrill Lynch. Proposed Nasdaq symbol RGNX. Business: Developing gene therapies for rare diseases with proprietary gene delivery platform.